Alex McDonald: Much Needed Information on the Management of LVT
Alex McDonald, Clinical Pharmacy Specialist at Spartanburg Regional Healthcare System, reposted from RPTH Journal on LinkedIn:
”Much needed information on the management of LVT.
Stay tuned for more data regarding the use of the elevated intensity phase of apixaban (7 days) and rivaroxaban (21 day).
Prefer not to call it a loading dose since it is more for clot dynamics than for pharmacokinetics.”
Quoting RPTH Journal‘s post:
”Left ventricular thrombus (LVT) is a dangerous complication. Until now, we’ve had limited evidence on how DOACs compare with VKAs.
A new Mayo Clinic multi-site study of 182 patients sheds some light:
- DOACs and VKAs had similar rates of embolism and thrombus resolution.
- VKAs, however, carried more major bleeding.
- The first 8 weeks remain the highest-risk window for embolization — suggesting a loading dose of DOAC could be worth exploring.
Important data for anyone managing cardiomyopathy or LVT.”
Read the full article in RPTH.
Article: Comparison of direct oral anticoagulants and vitamin K antagonists in the treatment of left ventricular thrombi: a retrospective cohort study
Authors: Hossam Elbenawi, Kirsten Lipps, Samuel Heller Jr., David A. Liedl, Raymond C. Shields, Ana I. Casanegra, Stanislav Henkin, Thom W. Rooke, Paul W. Wennberg, Waldemar E. Wysokinski, Robert D. McBane, Damon E. Houghton
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 19, 2026, 14:42Luca Palombi: Real-Time Assessment of Venous Hemodynamics During Movement With DUS
-
Feb 19, 2026, 14:41Cansu Kose: Cardiovascular Disease in Women Requires More Than Male-Derived Frameworks
-
Feb 19, 2026, 14:34Favour Kpokpe: Deep Dive Into the Kaggle Stroke Prediction Dataset
-
Feb 19, 2026, 14:28Sam K. Saha: A TIA Is A Warning Shot From A System On The Brink of Failure
-
Feb 19, 2026, 14:23Favour Felix-Ilemhenbhio: Parental Hypoxia Exposure Enhances Offspring Resilience to Stroke
-
Feb 19, 2026, 14:12Bhanu Hima Kumar Gadamsetti: 2018 vs 2026 AHA/ASA Acute Ischemic Stroke Guidelines
-
Feb 19, 2026, 14:10Gonçalo Ferraz Costa: Modern Thrombolytic Strategies and the Risk–Benefit Balance in Valve Thrombosis
-
Feb 19, 2026, 14:07Stéphanie Forté: New Insights on Stroke in Adults with Sickle Cell Disease
-
Feb 19, 2026, 14:00Hugh Kearney: Highlighting the Relevance of the Inflammasome in Multiple Sclerosis Pathophysiology